IMV presents positive lymphoma trial results
IMV Inc. has announced positive preliminary data from its VITALIZE phase 2B trial. The study…
February 14, 2023 - 3 minutes
IMV Inc. has announced positive preliminary data from its VITALIZE phase 2B trial. The study…